about
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsSalvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis.Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT.
P2860
Q24195048-48326648-4122-42D2-A5E9-CDCED2FA79CCQ33416874-E31DD267-FD6B-44F1-BBAF-691FFBF1AA80Q36543686-A232CAE9-6FAA-4F5D-989E-5B5CB2E45E10Q38849186-C0C52321-1C79-47D9-8683-F09B0D69D9C3Q41387926-A26DCA0D-5892-43EE-B9DF-A35EB9B1E7A2Q43413019-DDB47880-4C4C-446C-885E-82C374F268A9Q53041691-41750897-B563-409F-8CA8-525E79860E4E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comorbidity burden in patients with chronic GVHD
@en
Comorbidity burden in patients with chronic GVHD.
@nl
type
label
Comorbidity burden in patients with chronic GVHD
@en
Comorbidity burden in patients with chronic GVHD.
@nl
prefLabel
Comorbidity burden in patients with chronic GVHD
@en
Comorbidity burden in patients with chronic GVHD.
@nl
P2093
P2860
P356
P1476
Comorbidity burden in patients with chronic GVHD
@en
P2093
D Weisdorf
J M Palmer
P J Martin
P2860
P2888
P304
P356
10.1038/BMT.2013.70
P407
P50
P577
2013-05-13T00:00:00Z